Clinical Trial Update: Advanced Imaging Techniques for Evaluating the Tumor Immune Microenvironment in Glioblastoma Patients [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is planned to evaluate advanced imaging techniques for evaluating the tumor immune microenvironment in glioblastoma patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Glioblastoma | Phase 3 | Status: RECRUITING